| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/10/2010 | WO2010041863A9 Media composition for adipocyte differentiation |
| 06/10/2010 | WO2010039615A3 Papio cynocephalus toll-like receptor 3 |
| 06/10/2010 | WO2010022395A3 Methods of reprogramming cells |
| 06/10/2010 | WO2010017551A3 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion |
| 06/10/2010 | WO2010013012A4 Hypothermia inducing polypeptides and uses thereof |
| 06/10/2010 | WO2009150051A3 Biocompatible materials for mammalian stem cell growth and differentiation |
| 06/10/2010 | WO2009149956A3 Fusion protein and use thereof |
| 06/10/2010 | US20100146672 Compositions and methods for increasing cellulose production |
| 06/10/2010 | US20100146671 Targeting vector |
| 06/10/2010 | US20100146670 Methods and compositions for altering plant biomass |
| 06/10/2010 | US20100146669 Wall-associated kinase-like polypeptide mediates nutritional status perception and response |
| 06/10/2010 | US20100146668 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein |
| 06/10/2010 | US20100146663 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Modifying plant Characteristics |
| 06/10/2010 | US20100146661 Sugar beet genes involved in stress tolerance |
| 06/10/2010 | US20100146654 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 06/10/2010 | US20100146653 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus |
| 06/10/2010 | US20100146652 Xenobiotic related induction of gene expression |
| 06/10/2010 | US20100146651 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof |
| 06/10/2010 | US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 06/10/2010 | US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction) |
| 06/10/2010 | US20100146647 Antibody producing non-human mammals |
| 06/10/2010 | US20100146642 Methods and compositions relating to PBK1 |
| 06/10/2010 | US20100145470 Scaffolding for tissue regeneration or repair |
| 06/10/2010 | US20100145444 Method of preparing decellularized soft tissue, graft and culture material |
| 06/10/2010 | US20100145442 Ventricular assist device capable of implantation of stem cells |
| 06/10/2010 | US20100145441 Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient |
| 06/10/2010 | US20100145032 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| 06/10/2010 | US20100145024 Long wavelength engineered fluorescent proteins |
| 06/10/2010 | US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF |
| 06/10/2010 | US20100144847 Fusion polypeptide suitable as a cytotoxin |
| 06/10/2010 | US20100144845 Oligonucleotide systems for targeted intracellular delivery |
| 06/10/2010 | US20100144831 Blocking of gene expression in eukaryotic cells |
| 06/10/2010 | US20100144805 Regulation of protein synthesis |
| 06/10/2010 | US20100144798 Modulators of ATP-Binding Cassette Transporters |
| 06/10/2010 | US20100144737 Methods for inhibiting t helper cell differentiation |
| 06/10/2010 | US20100144720 Inhibitors of human tumor-expressed ccxckr2 |
| 06/10/2010 | US20100144685 Inhibiting cyclin d polypeptides |
| 06/10/2010 | US20100144678 Compositions and methods for treating bone cancer |
| 06/10/2010 | US20100144671 Compositions and Methods for Cancer Treatment |
| 06/10/2010 | US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 06/10/2010 | US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 06/10/2010 | US20100144627 Methods for modulating set and uses thereof |
| 06/10/2010 | US20100144605 Rescue of gonadotropin releasing hormone receptor mutants |
| 06/10/2010 | US20100144601 Anti-TNF Alpha Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses |
| 06/10/2010 | US20100144549 Parthenote-derived stem cells and methods of making and using them |
| 06/10/2010 | US20100144548 Vector systems |
| 06/10/2010 | US20100144543 Epigenetic silencing of tumor suppressor genes |
| 06/10/2010 | US20100144530 Identification of a new class of epsp synthases |
| 06/10/2010 | US20100144529 Identification of a new class of epsp synthases |
| 06/10/2010 | US20100144040 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 06/10/2010 | US20100144039 Pluripotency determining factors and uses thereof |
| 06/10/2010 | US20100144037 Disposable Tubing Set for Use with a Cell Expansion Apparatus and Method for Sterile Sampling |
| 06/10/2010 | US20100144036 Isolation of cells |
| 06/10/2010 | US20100144035 Delivery system for nucleic acids using cationic polymer conjugates |
| 06/10/2010 | US20100144034 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of Notch gene |
| 06/10/2010 | US20100144033 Suspension Culture of Human Embryonic Stem Cells |
| 06/10/2010 | US20100144032 Process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonc stem cells |
| 06/10/2010 | US20100144031 Methods for reprogramming somatic cells |
| 06/10/2010 | US20100144030 Method and Apparatus for Gender Selection Based on pH |
| 06/10/2010 | US20100144026 siRNA-mediated gene silencing with viral vectors |
| 06/10/2010 | US20100144014 Method for amplifying hcv in aedes mosquitoes |
| 06/10/2010 | US20100144004 Cell culture system, cell culture substrate thereof and culture method thereof |
| 06/10/2010 | US20100143975 Monoterpenoid modifying enzymes |
| 06/10/2010 | US20100143973 Interleukin-11 Fusion Proteins |
| 06/10/2010 | US20100143971 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 06/10/2010 | US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations |
| 06/10/2010 | US20100143945 Dna-damage-induced proteolysis |
| 06/10/2010 | US20100143944 Systems and methods for rapidly changing the solution environment around sensors |
| 06/10/2010 | US20100143936 Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof |
| 06/10/2010 | US20100143934 Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor |
| 06/10/2010 | US20100143918 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 06/10/2010 | US20100143915 Cells Modified or Altered for a Rice-diverged Glycosyltransferase |
| 06/10/2010 | US20100143896 Sequence capable of enhancing the expression of gene under moderately low temperature |
| 06/10/2010 | US20100143879 Apparatus and method for filter cleaning by ultrasound, backwashing and filter movement during the filtration of biological samples |
| 06/10/2010 | US20100143876 Transplant media |
| 06/10/2010 | US20100143503 Combinations of nitric oxide and sulfide and methods of use and manufacture thereof |
| 06/10/2010 | US20100143489 Synchronized water and production and use thereof |
| 06/10/2010 | US20100143477 Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof |
| 06/10/2010 | US20100143476 Composition for stimulating formation of vascular structures |
| 06/10/2010 | US20100143474 B-carboline for the treatment of neurodegenerative diseases |
| 06/10/2010 | US20100143457 Extended soluble PH20 polypeptides and uses thereof |
| 06/10/2010 | US20100143456 Model membrane systems |
| 06/10/2010 | US20100143442 Growth factor complexes and modulation of cell migration and growth |
| 06/10/2010 | US20100143435 Scaffold with increased pore size |
| 06/10/2010 | US20100143415 Streptococcus Pneumoniae Antigens |
| 06/10/2010 | US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 06/10/2010 | US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 06/10/2010 | US20100143409 Generation of virus-like particles and use as panfilovirus vaccines |
| 06/10/2010 | US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 06/10/2010 | US20100143404 Thiophene derivatives for up-regulating HLA-DM activity |
| 06/10/2010 | US20100143395 Material with immunogenicity |
| 06/10/2010 | US20100143376 Antibodies Specific for Rubella Virus |
| 06/10/2010 | US20100143371 Intrabodies |
| 06/10/2010 | US20100143368 Human Antibodies That Bind Cd22 And Uses Thereof |
| 06/10/2010 | US20100143367 Novel anti-cd98 antibody |
| 06/10/2010 | US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells |
| 06/10/2010 | US20100143362 LINGO binding molecules and Pharmaceutical Use Thereof |
| 06/10/2010 | US20100143360 Human vascular endothelial growth factor 2 |
| 06/10/2010 | US20100143359 Expression of foxp3 by cancer cells |
| 06/10/2010 | US20100143357 Uses of Mammalian Cytokine; Related Reagents |